News
📈 Stocks
North Immunology to Go Public via $180M Reverse Merger with Aethlon Medical
(52 days ago)
North Immunology secures $180 million and a Nasdaq listing via a reverse merger with Aethlon Medical to advance its dual-pathway inflammatory drug,…